Learn
Patient Navigation Program
Find Treatment Options
Expanded Access Programs
Brain Tumor Symptoms
Guide For High Grade Tumors
Guide For Low Grade Tumors
Checklist For Newly Diagnosed
Video Library
Noteworthy Treatments
Brain Tumor News
Survivor Stories
Fundraising
DC-Vax
Onc-201 for DIPG/DMG
Optune
Temodar (Temozolomide)
GammaTile
Newsletter
Subscribe
Change Email
Unsubscribe
Archives
Virtual Trial
What is it?
Join
Submit An Update
Map of Participants
Resources
Copayment Assistance Program
Drug Discount Card
Brain Tumor Centers
Support Groups
Links To Other Resources
Books
Memorials
About Us
Musella Foundation
Research Grants
Recent Additions To Website
Privacy Policy
Our Sponsors
Financials
Contact
donations
Sponsored by
Please click on the above banner for more details
Al's Comment:
This mutation is a bad prognostic sign, but they have a 15 year survivor on this medication.
Posted on: 11/05/2017
ONC201 Trial for Histone Mutant Glioma Begins at NYU
Click HERE to return to brain tumor news headlines.
Our privacy / cookie policy has changed.
Click HERE to read it!
